518 related articles for article (PubMed ID: 18230966)
1. The effect of sibutramine intake on resting and exercise physiological responses.
Rotstein A; Inbar O; Vaisman N
Ann Nutr Metab; 2008; 52(1):17-23. PubMed ID: 18230966
[TBL] [Abstract][Full Text] [Related]
2. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
[TBL] [Abstract][Full Text] [Related]
3. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
4. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
[TBL] [Abstract][Full Text] [Related]
5. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
Van Gaal LF; Wauters MA; De Leeuw IH
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
[TBL] [Abstract][Full Text] [Related]
6. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
7. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
Hauner H; Meier M; Wendland G; Kurscheid T; Lauterbach K; ;
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
[TBL] [Abstract][Full Text] [Related]
8. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Astrup A; Lundsgaard C
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
[TBL] [Abstract][Full Text] [Related]
9. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women.
Halford JC; Boyland EJ; Cooper SJ; Dovey TM; Huda MS; Dourish CT; Dawson GR; Wilding JP
J Psychopharmacol; 2010 Jan; 24(1):99-109. PubMed ID: 18755818
[TBL] [Abstract][Full Text] [Related]
10. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
Di Francesco V; Sacco T; Zamboni M; Bissoli L; Zoico E; Mazzali G; Minniti A; Salanitri T; Cancelli F; Bosello O
Ann Nutr Metab; 2007; 51(1):75-81. PubMed ID: 17356258
[TBL] [Abstract][Full Text] [Related]
11. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
[TBL] [Abstract][Full Text] [Related]
12. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females.
Walsh KM; Leen E; Lean ME
Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1009-15. PubMed ID: 10557020
[TBL] [Abstract][Full Text] [Related]
13. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
[TBL] [Abstract][Full Text] [Related]
14. [The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial].
Toubro S; Hansen DL; Hilsted JC; Porsborg PA; Astrup AV;
Ugeskr Laeger; 2001 May; 163(21):2935-40. PubMed ID: 11402974
[TBL] [Abstract][Full Text] [Related]
15. The effect of graded levels of exercise on energy intake and balance in free-living men, consuming their normal diet.
Stubbs RJ; Sepp A; Hughes DA; Johnstone AM; Horgan GW; King N; Blundell J
Eur J Clin Nutr; 2002 Feb; 56(2):129-40. PubMed ID: 11857046
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
[TBL] [Abstract][Full Text] [Related]
17. Resting and exercise energy use in Antarctica: effect of 50% restriction in temperate climate energy requirements.
Case HS; Reed HL; Palinkas LA; Reedy KR; Van Do N; Finney NS; Seip R
Clin Endocrinol (Oxf); 2006 Aug; 65(2):257-64. PubMed ID: 16886970
[TBL] [Abstract][Full Text] [Related]
18. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.
Kim SH; Lee YM; Jee SH; Nam CM
Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682
[TBL] [Abstract][Full Text] [Related]
19. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
[TBL] [Abstract][Full Text] [Related]
20. Influence of sibutramine on energy expenditure in African American women.
Starling RD; Liu X; Sullivan DH
Obes Res; 2001 Apr; 9(4):251-6. PubMed ID: 11331428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
